AFB/TB Identification | Test | Sprint Diagnostics Hyderabad

While M.tb is the leading cause of TB, infections with NTM species are also rising globally, particularly in individuals with weakened immune systems. NTM infections can manifest similarly to TB but often require different therapeutic strategies. Therefore, accurate identification of the infecting mycobacterial species is crucial for effective treatment planning.

No, fasting is not necessary for this test.

No specific preparation is required. However, the sample should be collected following the instructions given by your healthcare provider to ensure reliable results.

This test is usually ordered when a person has symptoms suggestive of a mycobacterial infection, such as a chronic cough, fatigue, weight loss, fever, night sweats, and chest pain, particularly when the person does not respond to initial antibiotic treatment.

This test provides valuable information on the presence and type of mycobacteria in the sample, distinguishing between M.tb and NTM species.

The frequency of the test depends on the clinical condition of the patient and the healthcare provider's judgment.

A normal result is no mycobacteria detected in the sample.

As this test deals with potential TB causing organisms, proper precautions should be taken during sample collection to prevent the spread of the bacteria.

Factors such as improper sample collection, sample contamination, and technical issues with the test process may affect test results.

If the test results are abnormal, you should consult with an infectious disease specialist or a pulmonologist.

Yes, some medications and health conditions could potentially impact the test results. It's important to inform your healthcare provider about any medications, supplements, or health conditions you have.

Yes, this test can be safely performed on pregnant women if needed.

The risks associated with this test are minimal and generally relate to the sample collection process.

The AFB/TB Identification (M.tb / MOTT) test is a reliable method for differentiating between M.tb and NTM infections.

Yes, this test can help diagnose TB by detecting and identifying M.tb in a sample. However, further tests may be required to confirm the diagnosis and guide treatment.

The AFB/TB Identification (M.tb / MOTT) test plays a vital role in the accurate diagnosis and effective treatment of mycobacterial infections. The results from this test can guide appropriate treatment strategies and lead to improved patient outcomes. It's important to follow the instructions provided by your healthcare provider and share any relevant medical history that might impact the test results.